REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/09/2026
Back to search
Official data from USPTO
EMD SERONO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EMD SERONO
ST13
US500000088220392Class
5, 9, 10, 16, 35, 41, 44
Filing
88220392
Registration
6285603
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/10/2026
Trademark type
Word
Nice classes
5, 9, 10, 16, 35, 41, 44
Filing date
12/06/2018
Registration date
03/09/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/09/2021
Last transaction
03/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/31/2007
First use in commerce
10/31/2007
Drawing code
4
Owner type
99
Owner location
Darmstadt, DE
Examiner
SCLEIDOROVICH, JOANNA YAEL
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MERCK KGAA
Representatives
William C. Wright EPSTEIN DRANGEL LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 16Class 35Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases and disorders of neurologyimmunologymetabolic endocrinologyinfertilityoncologyimmuno-oncology; prefilled syringes containing choriogonadotropin alfaprefilled syringes containing follitropin alfaprefilled syringes containing interferon beta-1aprefilled syringes containing cetrorelix
Class 9
Downloadable software in the nature of a mobile application that enables users to access healthcare information
Class 10
Medical apparatusinstruments and equipmentincubators and parts and fittings specially designed therefore used to support development of human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; injection devices for pharmaceuticals
Class 16
Printed instructional and teaching material in the field of healthcare
Class 35
Conducting business conferences in the healthcare area
Class 41
Providing training about the administration of drugs; conducting educational conferences in the healthcare area
Class 44
Providing medical informationconsultancy and advisory services
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/22/2020
PUBO
PUBLISHED FOR OPPOSITION
12/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/17/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/17/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/17/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/17/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/28/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/28/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/28/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2020
GNRT
NON-FINAL ACTION E-MAILED
04/23/2020
CNRT
NON-FINAL ACTION WRITTEN
04/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2019
GNRT
NON-FINAL ACTION E-MAILED
10/10/2019
CNRT
NON-FINAL ACTION WRITTEN
10/10/2019
DOCK
ASSIGNED TO EXAMINER
10/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/20/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/20/2019
GNRT
NON-FINAL ACTION E-MAILED
02/20/2019
CNRT
NON-FINAL ACTION WRITTEN
02/20/2019
DOCK
ASSIGNED TO EXAMINER
02/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2018
NWAP
NEW APPLICATION ENTERED
12/10/2018
Continuous trademark protection
Get notified about every new filing that threatens EMD SERONO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.